12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System: Phase III started

Boston Scientific began the single-blind, international Phase III EVOLVE II trial to compare its Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System vs. its marketed Promus Element Plus everolimus-eluting...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >